The Role of Chemotherapy in the Survival Benefits of Patients Aged Older Than 40 Years With Osteosarcoma

Objectives: The value of chemotherapy in the survival benefits of patients aged > 40 years with osteosarcoma is controversial. We aimed to explore the impact of chemotherapy on the survival benefits of patients aged >40 years with osteosarcoma. Methods: The Surveillance, Epidemiology, and End...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Zhiyou, Zhang, Yuelin, Xu, Qiang, Yu, Xiaolong, Liu, Xuqiang, Dai, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721374/
https://www.ncbi.nlm.nih.gov/pubmed/34918558
http://dx.doi.org/10.1177/15330338211066195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721374/
https://www.ncbi.nlm.nih.gov/pubmed/34918558
http://dx.doi.org/10.1177/15330338211066195

Ejemplares similares